Dilip D, Chandra A, Rajashekhar D, Padmanabhan M
Department of Cardiovascular and Thoracic Surgery, Sri Venkateswara Institute of Medical Sciences, Tirupati, India.
J Heart Valve Dis. 2001 May;10(3):294-300; discussion 300-1.
Impairment of left ventricular (LV) function after mitral valve replacement (MVR) has been the most important factor to determine morbidity and mortality. With this in mind, LV performance in the postoperative period was assessed with and without preservation of papillo-annular continuity in MVR.
Between March 1994 and August 1998, a total of 383 valve prostheses (202 MVR, 65 AVR, 58 MVR+AVR) were implanted in 325 patients, 177 of whom underwent MVR with Starr Edwards ball cage prostheses (the study group). Of these 177 patients, 105 had MVR with preservation of the posterior mitral leaflet (group I), and 72 had conventional MVR (group II). Predominant lesions were mitral stenosis in 81, mitral regurgitation in 42, and mixed mitral lesion (MS/MR) in 54. Concomitant tricuspid valve annuloplasty was performed in 13, and atrial septal defect repair in five. Sixteen patients underwent MVR for mitral restenosis. In-vivo performance of the prostheses and LV function was evaluated by M-mode and Doppler echocardiography.
At 3-6 months clinical improvement was seen in NYHA class, with reduction in cardiothoracic ratio among patients with preserved papillo-annular continuity, irrespective of lesion type. Significant reductions (p <0.05) were seen in left atrial dimensions (54.10 +/- 8.79 preop. versus 44.64 +/- 8.54 postop.; p <0.05), left ventricular end-diastolic dimensions (LVEDD) (50.84 +/- 10.42 preop. versus 41.21 +/- 7.16 postop.; p <0.05) and end-systolic dimensions (LVESD) (34.76 +/- 7.94 preop. versus 28.81 +/- 5.79 postop.; p <0.05) in patients who had their posterior mitral leaflet preserved with significant improvement in ejection fraction (60.31 +/- 8.22 versus 64.47 +/- 7.93; p <0.05). Further analysis of data in group I patients showed significant reductions in left atrial dimensions, LVESD and peak gradient, along with improved ejection fraction compared with conventional (group II) patients.
Deterioration in LV function in patients undergoing conventional MVR indicates chordal resection as a putative mechanism. This study supports the concept that maintenance of continuity between the mitral annulus and papillary muscles has a beneficial effect on postoperative LV function, and is particularly important in patients with mitral stenosis with depressed preoperative LV systolic function.
二尖瓣置换术(MVR)后左心室(LV)功能受损一直是决定发病率和死亡率的最重要因素。基于此,在MVR中评估了保留和不保留乳头肌 - 瓣环连续性情况下术后左心室的功能表现。
1994年3月至1998年8月期间,325例患者共植入了383个瓣膜假体(202个MVR,65个AVR,58个MVR + AVR),其中177例患者接受了使用Starr Edwards球笼式假体的MVR(研究组)。在这177例患者中,105例进行了保留二尖瓣后叶的MVR(I组),72例进行了传统MVR(II组)。主要病变为二尖瓣狭窄81例,二尖瓣反流42例,二尖瓣混合病变(MS/MR)54例。13例患者同时进行了三尖瓣环成形术,5例患者进行了房间隔缺损修复。16例患者因二尖瓣再狭窄接受MVR。通过M型和多普勒超声心动图评估假体的体内性能和左心室功能。
在3 - 6个月时,NYHA心功能分级有临床改善,保留乳头肌 - 瓣环连续性患者的心胸比率降低,与病变类型无关。保留二尖瓣后叶的患者左心房内径(术前54.10±8.79与术后44.64±8.54;p <0.05)、左心室舒张末期内径(LVEDD)(术前50.84±10.42与术后41.21±7.16;p <0.05)和收缩末期内径(LVESD)(术前34.76±7.94与术后28.81±5.79;p <0.05)显著减小,射血分数有显著改善(60.31±8.22与64.47±7.93;p <0.05)。对I组患者数据的进一步分析显示,与传统(II组)患者相比,左心房内径、LVESD和峰值梯度显著降低,射血分数提高。
接受传统MVR的患者左心室功能恶化表明腱索切除是一种可能的机制。本研究支持二尖瓣环与乳头肌之间保持连续性对术后左心室功能有有益影响的概念,这在术前左心室收缩功能低下的二尖瓣狭窄患者中尤为重要。